|
⚲
|
| Keyboard |
| Haller Julia A
✚
|
|
|---|---|
| CIK # | 0001656082 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001656082] | |
| 4 | [0001656082] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Haller Julia A | |
| Bristol Myers Squibb Co | |
| Outlook Therapeutics Inc | |
| Hyperion DEFI Inc | |
| Celgene Corp /DE/ |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2026-02-01 | Grant | 3,996.37 | $55.05 | 220,000 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2025-10-03 | Grant | 58,648 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2025-10-01 | Grant | 286,734 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2025-02-01 | Grant | 3,562.34 | $58.95 | 210,000 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-10-03 | Grant | 12,082 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-10-01 | Grant | 56,636 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-10-01 | Grant | 47,232 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Grant | 94,441 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2024-02-01 | Grant | 4,314.77 | $48.67 | 210,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2023-12-31 | Grant | 706.49 | $51.31 | 36,250 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2023-10-04 | Grant | 210,225 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2023-09-30 | Grant | 624.57 | $58.04 | 36,250 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2023-06-30 | Grant | 553.94 | $63.95 | 35,424 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2023-03-31 | Grant | 486.94 | $69.31 | 33,750 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2023-03-29 | Grant | 41,065 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2023-02-01 | Grant | 2,807.81 | $71.23 | 200,000 |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2022-12-31 | Grant | 469.08 | $71.95 | 33,750 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2022-10-05 | Grant | 42,239 | $0.00 | |
|
Bristol Myers Squibb Co BMY
Deferred Share Units · derivative
|
2022-09-30 | Grant | 474.75 | $71.09 | 33,750 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2022-08-11 | Grant | 25,000 | $0.00 | |
| showing 20 of 80 most recent transactions | |||||